Direct myocardial depressant effect of naloxone: Mechanical and electrophysiological actions in vitro

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 1, 2004, Pages 102-110

  Kim, Ki Jun ^a   Chung, Nam Sik ^c   Park, Wyun Kon ^a,b  

^a Anesthesia and Pain Research Institute   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c NONE

Author keywords

Antagonists; Cardiac: Contractility; Narcotic: Naloxone; muscle; Sarcoplasmic reticulum; heart: Ca 2+ current

Indexed keywords

CALCIUM; NALOXONE; SODIUM;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; MICROELECTRODE; MUSCLE ACTION POTENTIAL; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SWINE;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; COLD; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GUINEA PIGS; HEART; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NALOXONE; NARCOTIC ANTAGONISTS; PAPILLARY MUSCLES; PATCH-CLAMP TECHNIQUES; SODIUM;

EID: 0346725881     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2004.00267.x     Document Type: Article

References (35)

1. Faden AI, Holaday JW. Opiate antagonists: a role in the treatment of hypovolemic shock. Science 1979; 205: 317-8.
2. Gurll NJ, Vargish T, Reynolds DG, Lechner RB. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock. Surgery 1981; 89: 364-9.
3. Holaday JW, Faden AI. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 1978; 275: 450-1.
4. Faden AI, Holaday JW. Naloxone treatment of endotoxic shock: stereospecificity of physiologic and pharmacologic effects in the rat. J Pharmacol Exp Ther 1980; 212: 441-7.
5. Holaday JW, Faden AI. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Res 1980; 189: 295-300.
6. Faden AI, Jacobs TP, Mougey E, Holaday JW. Endorphins in experimental spinal injury, therapeutic effect of naloxone. Ann Neurol 1981; 10: 326-32.
7. Safani M, Blair J, Ross D, Waki R, Li C, Libby G. Prospective, controlled, randomized trial of naloxone infusion in early hyperdynamic septic shock. Crit Care Med 1989; 17: 1004-9.
8. Hackshaw KV, Parker GA, Roberts JW. Naloxone in septic shock. Crit Care Med 1990; 18: 47-51.
9. Lechner RB, Gurll NJ, Reynolds DG. Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock. Cir Shock 1985; 16: 347-61.
10. Allgood SC, Gurll NJ, Reynolds DG. Naloxone requires circulating catecholamines to attenuate the cardiovascular supression of endotoxic shock. J Surg Res 1988; 44: 73-81.
11. Lechner RB. Naloxone potentiates the inotropic effects of isoproterenol in vitro by a nonopiate receptor mechanism. Cir Shock 1992; 38: 157-64.
12. Gu H, Barron BA, Gaugl JF, Caffrey JL. (+) Naloxone potentiates the inotropic effect of epinephrine in the isolated dog heart. Circ Shock 1993; 40: 206-11.
13. Sagy M, Shavit G, Oron Y, Vidine BA, Gitter S, Sarne Y. Nonopiate effect of naloxone on cardiac muscle contractility. J Cardiovasc Pharmacol 1987; 9: 682-5.
14. Levin G, Gafni M, Roz N, Sarne Y. The involvement of sodium ions in the positive inotropic effect of naloxone. Gen Pharmacol 1993; 24: 423-8.
15. Thornhill J, St Onge R, Gregor L. Naloxone's effect on the inotropic and chronotropic responses of isolated, electrically stimulated or spontaneously beating rat atria. Can J Physiol Pharmacol 1989; 68: 392-401.
16. Brasch H. Influence of the optical isomers (+)-and (-)-naloxone on beating frequency, contractile force and action potentials of guinea-pig isolated cardiac preparations. Br J Pharmacol 1986; 88: 733-40.
17. Lechner RB. Naloxone potentiates inotropic but not chronotropic effects of isoproterenol in vitro. Cir Shock 1993; 39: 226-30.
18. Llobel F, Laorden ML. Effects of μ-, δ-, κ-opioid antagonists in atrial preparations from nonfailing and failing human hearts. Gen Pharmacol 1997; 28: 371-4.
19. Zhang X, Lee TS, Lee C. Naloxone increases cardiomyocyte contractility in rats. Anesthesiology 1997; 87: A556.
20. 2+ exchange in cardiac sarcolemma vesicles. Life Sci 1992; 51: 275-83.
21. Reiter M, Vierling W, Seibel K. Excitation-contraction coupling in rested-state contractions of guinea-pig ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 1984; 325: 159-69.
22. Bridge JHB. Relationship between sarcoplasmic reticulum and sarcolemmal calcium transport revealed by rapidly cooling rabbit ventricular muscle. J Gen Physiol 1986; 88: 437-73.
23. Reuter H, Scholz H. The regulation of the calcium conductance of cardiac muscle by adrenaline. J Physiol (Lond) 1977; 264: 49-62.
24. Repke DI, Katz AH. The stimulation of calcium transport in cardiac sarcoplasmic reticulum by adenosine 3′: 5′-monophosphate-dependent protein kinase. J Biol Chem 1974; 249: 6174-80.
25. 2+ release. Am J Physiol 1991; 260: H785-95.
26. Endoh M, Iijima T, Motomura S. Inhibition by theophylline of the early component of canine ventricular contraction. Am J Physiol 1982; 242: H349-58.
27. Bers DM. SR Ca loading in cardiac muscle preparations based on rapid-cooling contractures. Am J Physiol 1989; 256: C109-20.
28. Park WK, Pancrazio JJ, Suh CK, Lynch C III. Myocardial depressant effects of sevoflurane: mechanical and electrophysiological actions in vitro. Anesthesiology 1996; 84: 1166-76.
29. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 1981; 391: 85-100.
30. Fehr JJ, Rebeyka IM. Cooling and pH jump-induced calcium release from isolated cardiac sarcoplasmic reticulum. Am J Physiol 1994; 267: H962-9.
31. Balke CW, Rose WC, Marban E, Wier G. Macroscopic and unitary properties of physiological ion flux through T-type Ca2+ channels in guinea-pig heart cells. J Physiol (Lond) 1992; 456: 247-65.
32. Carratu' MR, Mitolo-Chieppa D. Inhibition of ionic currents in frog node of Ranvier treated with naloxone. Br J Pharmacol 1982; 77: 115-9.
33. Frazier DT, Ohta M, Narahashi T. Nature of the morphine receptor present in the squid axon. Proc Soc Exp Biol Med 1973; 142: 1209-14.
34. Holaday JW. Cardiovascular effects of the endogenous opiate systems. Annu Rev Pharmacol Toxicol 1983; 23: 541-94.
35. Sharma SK, Nirenberg M, Klee WA. Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci USA 1975; 72: 590-4.